[Treatment of dry eye with a new gel in eyedrop form].
Vidisic, a liquid gel derived from a polymerisate of acrylic acid for the treatment of dry eyes, was tested for 3 months in an open prospective study in 55 patients with severe dry eye. Vidisic spreads well over the cornea and conjunctiva and does not cause streaks. Compared with other tear substitutes so far available, Vidisic has a much longer viability, so that no more than 3 or 4 drops a day are necessary. Also, Vidisic is better tolerated and more effective. Moreover, there was a significant improvement, both subjectively and objectively, in the patients' conditions.
D000179:Acrylates / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D005782:Gels; D006801:Humans; D007637:Keratoconjunctivitis / Q000628:therapy*; D007638:Keratoconjunctivitis Sicca / Q000628:therapy*; D008297:Male; D009883:Ophthalmic Solutions / Q000627:therapeutic use*
D000179:Acrylates; D005782:Gels; D009883:Ophthalmic Solutions; C049065:vidisic
Die Behandlung des trockenen Auges mit einem neuen tropffähigen Gel.